Studies suggest muscle loss with GLP-1 receptor agonists ranges from fat-free mass (FFM) decreases of 25% to 39% of the total weight lost over 36 to 72 weeks
GLP-1 RAs have also demonstrated effectiveness for weight management and maintenance of weight loss in the treatment of people with overweight and obesity [4,5,6]
Individuals With Obesity and COVID-19: A Global Perspective on the Epidemiology and Biological Relationships
Beyond Raw LIT Advanced Formula PreWorkout for Men and Women, Energy, Focus, Endurance, Pumps, 300mg Rapid and Targeted Release Caffeine, Creatine, Betaine, Health And Medicine Destroy your limitations with the best pre-workout supplements from BEYOND RAW
Cao C., Yang S., and Zhou Z., GLP1 Receptor Agonists and Pancreatic Safety Concerns in Type 2 Diabetic Patients: Data From Cardiovascular Outcome Trials, Endocrine 68, no
Forces FDA to Reconsider 12 Peptides ProPublica: Peptide Safety Investigation New York Times: Peptide Ban FDA RFK Jr